Literature DB >> 19293567

Agreement in cognitive and clinical assessments in Alzheimer's disease.

Rochelle E Tractenberg1, Paul S Aisen.   

Abstract

AIMS: To estimate agreement among scores on three common assessments of cognitive function.
METHOD: Baseline responses on the Alzheimer's Disease Assessment Scale - Cognitive, Clinical Dementia Rating, and the Mini-Mental State Examination were obtained from two clinical trials (n = 138 and n = 351). A graphical method of examining agreement, the means-difference or Bland-Altman plot, was followed by Levene's test of the equality of variance corrected for multiple comparison within each sample.
RESULTS: 70-78% of variability was shared by one factor, suggesting that all three instruments reflect cognitive impairment. However, agreement among tests was significantly worse for individuals with greater-than-average, relative to individuals with less-than-average, cognitive impairment.
CONCLUSIONS: Worse agreement between tests, as a function of increasing cognitive impairment, implies that interpretation of these tests and selection of coprimary cognitive impairment outcomes may depend on impairment level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293567      PMCID: PMC2820316          DOI: 10.1159/000209212

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  18 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

2.  A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

Authors:  P S Aisen; K L Davis; J D Berg; K Schafer; K Campbell; R G Thomas; M F Weiner; M R Farlow; M Sano; M Grundman; L J Thal
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

3.  The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia.

Authors:  E F J Meulen; B Schmand; J P van Campen; S J de Koning; R W Ponds; P Scheltens; F R Verhey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

4.  The measurement of everyday cognition (ECog): scale development and psychometric properties.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Bruce R Reed; Deborah Cahn-Weiner; William Jagust; Kathleen Baynes; Charles Decarli
Journal:  Neuropsychology       Date:  2008-07       Impact factor: 3.295

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.

Authors:  R C Mohs; W G Rosen; K L Davis
Journal:  Psychopharmacol Bull       Date:  1983

8.  Application of item response theory for development of a global functioning measure of dementia with linear measurement properties.

Authors:  D Mungas; B R Reed
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

9.  Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach.

Authors:  Rochelle E Tractenberg; Paul S Aisen; Myron F Weiner; Jeffrey L Cummings; Gregory R Hancock
Journal:  Alzheimers Dement       Date:  2006-10       Impact factor: 21.566

10.  Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach.

Authors:  Rochelle E Tractenberg; Myron F Weiner; Jeffrey L Cummings; Marian B Patterson; Leon J Thal
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

View more
  3 in total

1.  Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.

Authors:  Soheila Hosseinzadeh; Maryam Noroozian; Esmaeil Mortaz; Kazem Mousavizadeh
Journal:  Metab Brain Dis       Date:  2017-12-05       Impact factor: 3.584

2.  Evaluation of cognitive impairment in elderly population with hypertension from a low-resource setting: Agreement and bias between screening tools.

Authors:  María Lazo-Porras; María A Pesantes; J Jaime Miranda; Antonio Bernabe-Ortiz
Journal:  eNeurologicalSci       Date:  2016-12-01

3.  Comparison of Instrumental Activities of Daily Living assessment by face-to-face or telephone interviews: a randomized, crossover study.

Authors:  Virginie Dauphinot; Nawèle Boublay; Claire Moutet; Sarah Achi; Anthony Bathsavanis; Pierre Krolak-Salmon
Journal:  Alzheimers Res Ther       Date:  2020-03-13       Impact factor: 6.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.